2073 studies found for:    Open Studies | "Hematologic Diseases"
Show Display Options
Rank Status Study
21 Unknown  "Pharmaco-economic Cost-effective Single-center Prospective Randomized Trial Evaluating the Open Interest Caphosol ® Mouthwashes in the Prevention and Treatment of Severe Oral Mucositis in Patients Receiving High-dose Chemotherapy in Hematology '
Condition: Hematologic Disease
Interventions: Device: Caphosol;   Drug: Bicarbonate de sodium
22 Recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma;   Lymphoma, Primary Cutaneous Anaplastic Large Cell;   Lymphomatoid Papulosis;   Mycosis Fungoides;   Skin Lymphoma;   Cutaneous Lymphomas;   Lymphoma;   Hematologic Disorder
Intervention: Drug: SGN-35
23 Not yet recruiting Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Condition: Hematologic Disorder
Interventions: Drug: Lenalidomide;   Biological: Influenza Vaccine;   Biological: Pneumovax Vaccine
24 Recruiting Dexamethasone Dyspnea Study
Conditions: Advanced Cancers;   Hematologic Disorder;   Solid Tumors
Interventions: Drug: Dexamethasone;   Drug: Placebo;   Behavioral: Questionnaires;   Device: Spirometer;   Other: Phone Calls
25 Recruiting Stem Cell Transplant for Hematologic Diseases
Condition: Hematologic Malignancies
Interventions: Biological: Campath 1H;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Radiation: Total Body Irradiation (TBI);   Drug: FK506 (Tacrolimus) or Cyclosporin
26 Recruiting The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases
Condition: Chronic Lymphoid Leukemia
Interventions: Drug: Cholecalciferol;   Drug: oleum neutralicum
27 Not yet recruiting Occupational Status and Hematological Disease
Conditions: Chronic Myeloid Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Chronic Thrombocytopenia;   Hodgkin Disease
Interventions: Behavioral: Study questionnaire;   Behavioral: SF-36 Questionnaire
28 Recruiting Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Conditions: Neoplasms;   Hematologic Neoplasms
Intervention:
29 Recruiting Diamond Blackfan Anemia Registry (DBAR)
Conditions: Anemia;   Blood Disease
Intervention:
30 Recruiting Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function
Conditions: Stem Cell Transplantation, Hematopoietic;   Poor Graft Function;   Hematological Diseases
Interventions: Biological: PBSC;   Biological: MSCs
31 Recruiting Donor Lymphocyte Infusion for Treatment of CMV Infection
Conditions: Stem Cell Transplantation, Hematopoietic;   CMV Infection;   Hematological Diseases
Interventions: Biological: DLI;   Biological: MSCs
32 Unknown  Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation
Conditions: Hematological Diseases;   Allogeneic Stem Cell Transplantation
Intervention: Drug: itraconazole
33 Recruiting Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
Conditions: Cancer;   Hematologic Disorders
Intervention: Device: Catheter Resistance Monitoring
34 Recruiting Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation
Condition: Hematological Diseases
Intervention:
35 Unknown  Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
Condition: Hematological Disease
Intervention: Other: Supervised exercise
36 Unknown  Exercise During Chemotherapy for Patients With Hematological Malignancies
Conditions: Hematological Diseases;   Hematological Malignancies
Interventions: Other: Aerobic exercise;   Behavioral: Fatigue counseling
37 Recruiting Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Conditions: Hematologic Disorders;   Hemoglobinopathies;   Immunodeficiencies;   Inherited Metabolic Disorders
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Radiation: Total body irradiation;   Biological: Stem cell transplant;   Drug: Keppra
38 Recruiting Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Stem Cell Transplantation, Hematopoietic;   Mesenchymal Stem Cells;   Poor Graft Function;   Hematological Diseases
Intervention: Biological: Mesenchymal stem cells
39 Recruiting Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
Conditions: Hematopoietic Stem Cell Transplantation;   Mesenchymal Stem Cells;   Umbilical Cord Blood;   Graft Failure;   Hematological Diseases
Interventions: Biological: Mesenchymal stem cells;   Biological: Mesenchymal stem cells and cord blood
40 Unknown  Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Condition: Hematopoietic/Lymphoid Cancer
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years